In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series

BACKGROUND: Patients with metastatic Merkel cell carcinoma (mMCC) who experience disease progression on immunotherapy have limited additional standard options. Given evidence of synergism between radiation therapy (RT) and immunotherapy, two patients progressing on PD-1 inhibition were referred for...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Melody J., Wu, Susan, Daud, Adil I., Yu, Siegrid S., Yom, Sue S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977737/
https://www.ncbi.nlm.nih.gov/pubmed/29848371
http://dx.doi.org/10.1186/s40425-018-0352-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977737/
https://www.ncbi.nlm.nih.gov/pubmed/29848371
http://dx.doi.org/10.1186/s40425-018-0352-8

Ejemplares similares